Compare Ginkgo Bioworks Holdings Inc (DNA) vs ProShares UltraPro S&P500 (UPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs ProShares UltraPro S&P500 — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while ProShares UltraPro S&P500 trades at $154.52. The key difference: ProShares UltraPro S&P500 is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | UPRO | |
|---|---|---|
Market Cap | $505.73M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $16.14 | $155.10 |
52-Week Low | $5.48 | $89.29 |
Enterprise Value | $607.68M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About ProShares UltraPro S&P500
UPRO is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the S&P 500 Index. It is a tactical, high-conviction instrument designed for short-term traders to amplify bullish market moves, utilizing a daily reset mechanism that creates significant compounding effects and volatility risks over time.
Read more on UPRO →
